A 63-year-old female, who had been diagnosed with rheumatoid arthritis (RA) 3 years previously, was admitted due to progressive pancytopenia, lymphadenopathy, fever, and weight loss. The physical and laboratory findings fulfilled all of the American Rheumatism Association (ARA) revised criteria for RA. Her bone marrow aspirate revealed a decreased nuclear cell count (1.8xlO4/|il) and megakaryocyte count (0/jol), and macrophages phagocytizing blood cells (4%), indicating the presence of hemophagocytic syndrome. The serological tests for several viruses revealed no obvious viral etiology. However, a slight Epstein-Barr virus (EBV)reactivation could not be excluded. Administration of40 mgprednisolone daily improved her abnormal hematological findings and immunological laboratory parameters. This is a case of RAaccompanied by hemophagocyticsyndrome, which has not been reported previously as a complication of RA. (Internal Medicine 33: 607-611, 1994) Keywords: Epstein-Barr virus, systemic lupus erythematosus Case Report A 63-year-old woman, who had been previously diagnosed with rheumatoid arthritis (RA) in 1989, was referred to our department by her family doctor in June 1992 for progressive anemia and thrombocytopenia. In March 1 99 1 her hemoglobin was 10.2 g/dl, dropping to 8.0 g/dl by February 1992. Her platelet count was 15.5x104/|ll1 in March 1992, rapidly decreasing to 5.7xl04/|nl in May 1992. She had apoor appetite, lost 17 kg over 4 months, and had a fever for a week. Physical examination revealed a malar rash on her face, anemic conjunctiva, multiple lymphadenopathy less than 2 cm in diameter, petechiae and ecchymoses on the trunk and limbs, and a subcutaneous nodule on the extensor surface of her left forearm. There were typical rheumatoid deformities in her hands. Her liver and spleen were not palpable and an abdominal sonogram showed that they were normal size. She had a continuous fever between 37.5-38.5°C. Laboratory parameters included a red blood cell count of 1.9xlO6/|il, hemoglobin level 5.8 g/dl, white blood cell (WBC) count 2,400/|il with 5 1% neutrophils, 23% lymphocytes and 16%monocytes, a platelet count of 5.6xlO4/|il, and 2.0% reticulocytes. Serum chemistry, including serum bilirubin, was within normal ranges except for GOT(AST) of 58 IU/L and LDH of 545 IU/L (normal 8-35 and 184^60 IU/L, respectively). Her serum ferritin was 1 ,700 ng/ml (normal 8-74 ng/ ml), serum iron 94 jug/dl (normal 48-154 Jig/dl), and total iron binding capacity (TIBC) 172 jug/dl (normal 246-396 jag/dl), although she had been administered iron intravenously by her family doctor. Bone marrow aspirate revealed a decreased nuclear cell count (1.8x104/jj1) and megakaryocyte count (0/ |Lil), and an increased level of macrophages (4%). The macrophageshad a low nuclear/cytoplasmic ratio, mature nuclear chromatin pattern, and abundant cytoplasm including multiple vacuoles. They showed phagocytosis of blood cells including erythroblasts, myeloid cells, and platelets (Fig. 1) . Immunological examinations revealed positive LE cells, high titers ofRAHA ( 1 :2,560) and antinuclear antibody (ANA) [ 1 :320] , and elevated double stranded DNA(dsDNA) antibody (52 U/ml; normal <10 U/ml). It was also demonstrated that the levels of complements were decreased: <12.0 U/ml CH50, 17 mg/dl C3, and <3 mg/dl C4 (normal 30.0-40.0 U/ml, 60-1 16 mg/dl, and 1 5-^4 mg/dl, respectively). The concentration of the immunecomplexes as measured by anti-Clq was increased to 83.4 |Lig/ml (normal <34.5 |ig/ml). Assays for extractable nuclear antigens (ENA) antibody, nuclear ribonucleo-protein (RNP) antibody, Sm antibody, SS-A/Ro antibody, and SS-B/La antibody, and both direct and indirect Coombs' tests were negative. The titers of antibodies to the Epstein-Barr (EB) virus as measured by immunofluorescence assay (IF) were as fol-
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Biopsies of an inguinal lymph node and skin from her cheek were performed. Histologically, the lymph node revealed follicular hyperplasia while hemophagocytosis was not seen. Her epidermis was atrophic with liquefaction degeneration at the basal layer and perivascular infiltration of inflammatory cells in the upper dermis, which was compatible with systemic lupus erythematosus (SLE). mg prednisolone daily. Her fever subsided rapidly and the malar rash on her cheek was gradually diminished after the administration of corticosteroids. Her hematological abnormalities gradually improved and by day 14 of corticosteroid therapy the following hematological findings were recorded: hemoglobin 7.6 g/dl; WBCcount 5,500/jil; and platelet count 1 1.0x l04/|al. The fluorescence intensity of the CD4antigen was restored after therapy ( Fig. 2E-H 
Discussion
The present patient had been diagnosed with RA and treated for 3 years. She met all of the revised criteria for RAof the American College of Rheumatology (1), and the destructive changes demonstrated in the hand roentgenogram supported the diagnosis of RA. It is well known that connective tissue diseases are frequently complicated by hematologic abnormalities (2). Approximately 60%ofRA patients have anemia knownas "chronic disease anemia," and its severity is usually mild to moderate. Pancytopenia caused by drugs such as gold, D-penicillamine, and NSAIDsis also seen in some patients. Although Felty's syndromecan cause severe pancytopenia, splenomegaly, which is characteristic of Felty's syndrome, was not found in this patient.
The patient met three of the revised criteria for SLE (3): malar rash, immunologicabnormalities with the presence of dsDNAantibody, and positive ANA.Her serum complement levels were decreased and elevated levels of immunecomplexes were noted. Although "hematologic abnormalities" is one of the criteria for SLE, her hematologic abnormalities did not include hemolytic anemia, lymphopenia, or thrombocytopenia due to the autoimmune mechanism (4). The present patient showed normal levels of GOT, LDH, and bilirubin, and reduced levels of reticulocyte (0.3 to 0.6%), except on the day of admission when the levels were all slightly elevated. Hemolytic anemia was thought to have little or no contribution to the development of severe anemia. Furthermore, a reduced level ofmegakaryocytes was found in her bone marrow, suggesting that autoimmune mechanisms, such as idiopathic thrombocytopenic purpura, were unlikely. Several studies have found an increase or a decrease in the percentage of CD4+T cells in patients with autoimmune diseases. A case of hemophagocyticsyndromewith a marked Internal Medicine Vol. 33, No. 10 (October 1994) decrease in the percentage of CD4cells was reported by Arya and colleagues (5) . They discussed the relation between the immunological abnormality and the hemophagocytosis in their patient. However, a specific decrease in the fluorescence intensity of the CD4antigen combined with a normal number of CD4+T cells has not been reported and suggests changes in the cell surface membrane.Similar changes were probably present in other immunological cells, and these changes could affect the interaction between macrophages and blood cells. Moreover, cytokines secreted by these "abnormal" T cells could have someinfluence on macrophages,resulting in the malfunction of macrophagesand hemophagocytosis. Since 19 cases of virus-associated hemophagocytic syndrome were reported by Risdall et al in 1979 (6) (20) (21) (22) and that B cells in the blood of patients with RAare frequently infected by EB viruses (23) . It has been reported that EBVis involved in the production of autoantibodies in SLE (24) . The exact mechanism by which HS and "SLE-like" symptoms developed in the present patient has remained unclear.
One possible explanation is that the patient' s "SLE-like" symptoms and concomitant HS was induced by the reactivation of EBV; a state which has been popularly reported in RApatients. Another explanation is that underlying immunological abnormalities in RAare directly related to the development of HS and "SLE-like" symptoms, since successful therapeutic intervention of both HSand "SLE-like" symptoms by steroid was not inevitably associated with the alteration of the EBVreactivated state. Wecannot determine whether the EBVreactivation is related to her "SLE-like" symptoms and HS, or it developed by chance as one of the typical immunological abnormalities in RApatients. There have been no previous reports on HSas a complication of RA.
